---
title: "ROSEN，一家備受信賴的領先律師事務所，敦促紐爾真檢測公司投資者在證券集體訴訟的重要截止日期之前獲取法律諮詢"
description: "紐約，2025 年 8 月 9 日（GLOBE NEWSWIRE）——為什麼：羅森律師事務所，一家全球投資者權益律師事務所，提醒在 2023 年 1 月 5 日至 2025 年 6 月 3 日期間（“訴訟期間”）購買 Neogen Corporation（NEOG）普通股的投資者，注意 2025 年 9 月 16 日的重要首席原告"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/252338188.md"
published_at: "2025-08-09T14:09:45.000Z"
---

# ROSEN，一家備受信賴的領先律師事務所，敦促紐爾真檢測公司投資者在證券集體訴訟的重要截止日期之前獲取法律諮詢

> 紐約，2025 年 8 月 9 日（GLOBE NEWSWIRE）——為什麼：羅森律師事務所，一家全球投資者權益律師事務所，提醒在 2023 年 1 月 5 日至 2025 年 6 月 3 日期間（“訴訟期間”）購買 Neogen Corporation（NEOG）普通股的投資者，注意 2025 年 9 月 16 日的重要首席原告

NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation NEOG between January 5, 2023 and June 3, 2025, inclusive ( the "Class Period" ) , of the important September 16, 2025 lead plaintiff ...

### Related Stocks

- [NEOG.US - 紐爾真檢測](https://longbridge.com/zh-HK/quote/NEOG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Neogen CEO Mikheal Nassif Reports Acquisition of Common Shares | Mikheal Nassif, CEO of Neogen Corporation, announced the acquisition of common shares of the company. The full filing is | [Link](https://longbridge.com/zh-HK/news/274560850.md) |
| Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination | Neogen Corporation has initiated a voluntary recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium St | [Link](https://longbridge.com/zh-HK/news/274186608.md) |
| Neogen CEO Mikheal Nassif Acquires Common Shares | Mikheal Nassif, CEO and Director of Neogen Corporation, has acquired common shares of the company. The full filing is av | [Link](https://longbridge.com/zh-HK/news/272846760.md) |
| Neogen beats Q2 revenue estimates, raises guidance | Neogen's Q2 revenue fell 2.8% but exceeded analyst expectations, with adjusted net income and EBITDA also beating estima | [Link](https://longbridge.com/zh-HK/news/271929303.md) |
| Neogen Non-GAAP EPS of $0.10 beats by $0.03, revenue of $224.7M beats by $16.32M | Neogen Non-GAAP EPS of $0.10 beats by $0.03, revenue of $224.7M beats by $16.32M | [Link](https://longbridge.com/zh-HK/news/271929891.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。